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Abstract
Background: In a context of increasing demand and pressure on the public health expenditure, appropriateness of
colonoscopy indications is a topic of discussion. The objective of this study is to evaluate the appropriateness of
colonoscopy requests performed in a primary care (PC) setting in Catalonia.
Methods: Cross-sectional descriptive study. Out-patients >14 years of age, referred by their reference physicians from
PC or hospital care settings to the endoscopy units in their reference hospitals, to undergo a colonoscopy. Evaluation
of the appropriateness of 1440 colonoscopy requests issued from January to July 2011, according to the EPAGE-II
guidelines (European Panel on the Appropriateness of Gastrointestinal Endoscopy).
Results: The most frequent indications of diagnostic suspicion requests were: rectal bleeding (37.46 %), abdominal pain
(26.54 %), and anaemia study (16.78 %). The most frequent indications of disease follow-up were adenomas (58.1 %), and
CRC (31.16 %). Colonoscopy was appropriate in 73.68 % of the cases, uncertain in 16.57 %, and inappropriate in 9.74 %.
In multivariate analysis, performed colonoscopies reached an OR of 9.9 (CI 95 % 1.16–84.08) for qualifying as appropriate
for colorectal cancer (CRC) diagnosis, 1.49 (CI 95 % 1.1–2.02) when requested by a general practitioner, and 1.09 (CI 95 %
1.07–1.1) when performed on women.
Conclusions: Appropriateness of colonoscopy requests in our setting shows a suitable situation in accordance with
recognized standards. General practitioners contribute positively to this appropriateness level. It is necessary to provide
physicians with simple and updated guidelines, which stress recommendations for avoiding colonoscopy requests in
the most prevalent conditions in PC.
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Background
Colonoscopy is an endoscopic examination which en-
ables accurate location of lesions, and obtaining biopsies.
Most conditions that affect the lower gastrointestinal
tract can be diagnosed by colonoscopy, and some thera-
peutic procedures may be performed simultaneously [1].
Colonoscopy is the most sensitive and specific test to
detect adenomas and colorectal cancer (CRC).
Colonoscopy requests have significantly increased over
the last years as a consequence to the efficacy shown in
the CRC screening. [2, 3]. Colonoscopy is considered the
test of choice in high risk patients (family history of
CRC and/or personal history of advanced adenomas,
and is the diagnostic confirmation test when the faecal
occult blood test (FOBT) is positive [4].
In developed countries, CRC represents the second
cause of incidence and mortality for cancer, both in men
and women, occupying the first place when considering
both sexes [5]. In Spain, in 2012, CRC was diagnosed in a
total of 32,240 cases (19,261 men, and 12,979 women),
and was responsible for the death of 14,700 people (8,742
men and 5,958 women) [5]. EUROCARE-5 study results
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for Spain, estimate a 5-year survival rate for CRC of 57.1
(CI 95 % 56.1–58.1) and a 5-year survival rate for rectal
cancer of 56.4 (CI 95 % 55.0–57.7) [6].
Long term results from the National Polyp Study con-
firmed that adenoma removal in high risk CRC patients
reduces incidence and mortality for CRC [7, 8]. In con-
trast, follow-up strategies are not clearly established in
patients with low-risk adenomas. Moreover, published
studies show that some patients with high-risk CRC do
not receive adequate follow-up, compared to a great deal
of low-risk CRC patients, who undergo too many colon-
oscopies [9, 10].
Colonoscopy is indicated to evaluate signs and symp-
toms of CRC suspicion (rectal bleeding, changes in bowel
habit, abdominal pain, anaemia, etc.), which are common
reasons for primary care (PC) consultation, and are usu-
ally caused by benign limited conditions [11]. Adequate
management of patients presenting these symptoms,
should involve an initial assessment which considers the
balance between necessity of knowing the symptoms aeti-
ology and the performance of a colonoscopy, taking into
consideration age and accompanying symptoms.
Colonoscopy, either used as a screening test, a diagno-
sis confirmation tool, or a therapeutic procedure, is not
free from complications [12, 13]. Its diagnostic cost-
effectiveness improves with a correct bowel preparation,
and when performed under sedation [12, 13]. Colonos-
copy cost-effectiveness is also correlated to the health fa-
cilities and availability of trained staff. These factors affect
the quality offered by the different endoscopy units which,
therefore, is not always homogeneous [12, 13].
Open-access endoscopy units allow physicians to re-
quest colonoscopies directly, without previous consult-
ation to the gastroenterologist. In a context of increasing
demand and pressure on the public health expenditure,
appropriateness of colonoscopy indications is a topic of
discussion. Various scientific institutions as the Euro-
pean Panel of Appropriateness of Gastrointestinal En-
doscopy (EPAGE) [14] and the American Society for
Gastrointestinal Endoscopy (ASGE) [15], have devel-
oped different guidelines on the appropriate indication
of colonoscopy. The general practitioner, for his/her
closeness and accessibility to the public, for his/her
continuity of assistance, and for the characteristics of
the health problems he/she is involved with, plays a key
role in the rational use of colonoscopy.
In our PC setting, no studies on evaluation of the appro-
priateness of colonoscopy have been published to date. It
is for this reason that the following study has been pre-
sented, its objectives being: 1) To evaluate the appropri-
ateness of colonoscopy requests issued on a PC setting in
Catalonia, according to the EPAGE-II appropriateness
guidelines, and 2) To evaluate the possible associations of
appropriateness of colonoscopy with the indication of
colonoscopy, professional who makes the request for the





Two health districts in Catalonia (the South-Metropolitan
and Central Catalonia districts) assigned to the following
participating reference Hospitals: Hospital Universitari
de Bellvitge, Hospital de Viladecans, Hospital Comarcal
de l’Alt Penedès, Hospital de Sant Joan Despí, Moisès
Broggi, Hospital General de L’Hospitalet and Hospital
General d’Igualada.
Period study
From January 2011 to July 2011.
Population sample
Out-patients >14 years of age referred by their refer-
ence physicians (gastroenterologists, surgeons, and gen-
eral practitioners), from primary care or hospital
settings to the endoscopy units in their reference hospi-
tals, to undergo a colonoscopy. Neither colonoscopy re-
quests issued from the public health CRC screening
program, introduced in some areas where the study was
implemented, nor requests from hospital in-patients
were included.
Sample calculation
A sample of 1440 colonoscopy requests was required to
determine an appropriateness level of at least 50 %, as
situation of maximum uncertainty, with an absolute pre-
cision of 4 % and a 95 % confidence interval. A design
effect of 1.9 was determined on the cluster sampling
(hospitals), and a 20 % of requests were considered ineli-
gible. (Data analysis was performed using the epidemio-
logical data analysis program Epidat 3.1; Dirección Xeral
de Innovación e Xestión da Saúde Pública. Conselleria
de Sanidade. Xunta de Galicia).
Data collection
All colonoscopy requests which met the inclusion criteria
were collected systematically, from the available request
lists at every participating reference hospital, in chrono-
logical order, up to a maximum of 250 requests per hos-
pital. Information regarding patient characteristics and
request indication was obtained from the colonoscopy re-
quests. This information was complemented with the elec-
tronic patient records, from which colonoscopy results
were also obtained. All information was collected by
health professionals (physicians and nurses) using an
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optical data collection sheet (Teleform 4.0 for Windows,
Cardiff Software, Inc., Solana Beach, CA, 1996).
Main outcome
Appropriateness of colonoscopies was decided according
to the EPAGE-II criteria. Evaluation was performed by
peer review, with the participation of a first reviewer (a
clinician), different in every hospital, and a second re-
viewer (an epidemiologist) common to all hospitals, with a
final agreement by consensus, for discrepancy cases.
EPAGE criteria were developed and validated by a multi-
disciplinary panel of 14 European experts, in 1998, and
later reviewed in 2009 (EPAGE-II criteria). EPAGE-II cri-
teria classify indications for colonoscopy into 11 sections,
which are scored from 1 (extremely inappropriate) to 9
(extremely appropriate) depending on clinical indication,
age, personal and family history. These criteria classify ap-
propriateness of colonoscopy into 3 possible categories:
appropriate (≥7), uncertain (4–6), and inappropriate (≤3)
[14]. Besides the classification according to the EPAGE-
II criteria, the variable appropriateness of colonoscopy
was transformed into a dichotomous variable, with a
cut-off point of 7 (<=6 inappropriate request; > = 7 ap-
propriate request).
Other studied variables
Variables on the social and demographic patient charac-
teristics, clinician requesting the procedure, clinical indi-
cation of request, results report, diagnosis, and diagnosis
relevance were collected. Relevant diagnoses, for this
study, were established as: CRC, adenomas, diverticular
disease, and intestinal inflammatory disease (IID), which
includes ulcerative colitis and Crohn’s disease. The
whole set of variables can be consulted on the published
study protocol [16].
Statistical analysis
A descriptive analysis was performed on patient charac-
teristics, clinician requesting the procedure, clinical in-
dication of colonoscopy request, and relevance of the
identified lesions. Appropriateness level was deter-
mined according to the EPAGE-II criteria (appropriate,
uncertain or inappropriate request) globally, and for
each indication.
A bivariate analysis for appropriateness of colonoscopy
was performed on two categories (cut-off point of 7 on
the EPAGE-II scoring system), according to patient fac-
tors, requesting clinician factors and diagnosis relevance.
Differences between groups were assessed using a χ2 test
or a Fisher’s exact test, depending on the applying condi-
tions, to compare categorical variables, and Student’s t-
test or nonparametric tests (Mann–Whitney U test) to
compare continuous variables, according to the variable
normal distribution. A 5 % level of significance was used
in all contrasts.
Subsequently, a multivariate analysis by multilevel lo-
gistic regression was conducted, to assess variables as-
sociated to appropriateness, in two categories, after
stratification for hospital. For that, the independent var-
iables from the bivariate analysis, which represented a p
value ≤0.10 or that were of clinical relevance according
to the literature, were considered. In addition, a final
model was obtained by progressively excluding those
variables which did not provide variability, according to
the Akaike information criterion.
Finally, a secondary analysis to establish the correl-
ation between the initial score (first reviewer) and final
score (consensus) on the peer review was performed by
the intraclass correlation coefficient, considering the
cut-off point of 0.75 proposed by Fleiss [17]. This ana-
lysis was complemented with the Spearman’s rank cor-
relation coefficient, applying the criteria for quantitative
significance recommended by Burnand et al.: r < 0.30 =
insignificant; 0.30–0.45 =moderate; 0.45–0.60 = substan-
tial; and r > 0.60 = high [18]. Statististical analysis was
conducted using statistical packages implemented in en-
vironment R v.2.14.2.
Ethics issues
The study protocol was approved to the ethics commit-
tee of the Clinical Research Ethics Commitee of the Uni-
versity Institute in Primary Care Research Jordi Gol
(IDIAP Jordi Gol) (http://www.idiapjgol.org/). Individu-
alized informed consent was not obtained from the par-
ticipating patients, because it was not considered
necessary according to national regulations [19]. Infor-
mation was collected anonymously from colonoscopies
request forms and computerized records by health care
professionals in each centre.
Results
A total of 1478 colonoscopies were included over the
6 months the study took place. As shown in Table 1, each
reference hospital provided from 241–250 colonoscopies
(H1-H6). Average patient age was 59.6 years and 50.06 %
were women. Regarding its origin, 54.66 % of the requests
were issued from primary care centres (PCC). The highest
percentage of colonoscopies was requested by general
practitioners. Percentages on colonoscopy origin of re-
quest and type of requesting clinician significantly varied
among the different hospitals.
Table 2 shows colonoscopy characteristics. Most col-
onoscopies were requested as routine requests (69.72 %),
percentage which differs significantly depending on the
reference hospital. The highest percentage of colonos-
copies responds to the indication of diagnostic suspicion
(64.47 %), whilst opportunistic screening represents the
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Table 1 Characteristics of patients with colonoscopy request, origin of the request, and type of requesting clinician, depending on
participating reference hospital. Results are expressed as mean (standard deviation) and n (%)
Total (n = 1478) H1 (n = 245) H2 (n = 245) H3 (n = 250) H4 (n = 250) H5 (n = 247) H6 (n = 241)
Agea 59.6 (15.0) 58.9 (15.7) 59.7 (14.4) 59.6 (14.9) 58.7 (14.8) 59.2 (15,1) 61.7 (15,1)
Women 740 (50.06 %) 111 (45.30 %) 122 (49.79 %) 126 (50.40 %) 133 (53.20 %) 124 (50.20 %) 124 (51.45 %)
Origin (gathered)
SCC and outpatients 662 (44.79 %) 124 (50.61 %) 142 (57.95 %) 137 (54.80 %) 68 (27.20 %) 121 (49,98 %) 70 (29,04 %)
PCC 808 (54.66 %) 121 (49.38 %) 102 (41.63 %) 113 (45.20 %) 179 (71.60 %) 122 (49,39 %) 171 (70.95 %)
Requesting clinician
General practitioner 790 (53.45 %) 119 (48.57 %) 95 (38.36 %) 113 (45.20 %) 172 (68.80 %) 121 (48,98 %) 170 (70.53 %)
Gastroenterologist 426 (28.82 %) 21 (8.57 %) 134 (54.69 %) 91 (36.40 %) 65 (26.00) 59 (243,88 %) 56 (23.23 %)
Surgeon 152 (10.28 %) 48 (19.59 %) 8 (3.26 %) 40 (16.00 %) 3 (1.20 %) 40 (16,19 %) 13 (5.18 %)
Internist 27(1.82 %) 16 (6.53 %) 0 (0.00 %) 3 (1.20 %) 0 (0,00 %) 7 (2,83 %) 1 (0.41 %)
Other 51 (3.45 %) 28 (11.42 %) 0 (0.00 %) 3 (1.20 %) 1 (0.40 %) 19 (7,69 %) 0 (0.00 %)
aAge expressed as mean ± standard deviation
SCC Specialized care centre, PCC Primary Care Centre
Table 2 Colonoscopy characteristics depending on participating reference hospital. Results are expressed as n (%)
Total (n = 1478) H1 (n = 245) H2 (n = 245) H3 (n = 250) H4 (n = 250) H5 (n = 247) H6 (n = 241) P
Prioritya <0,001
Routine 919 (69.72 %) 171 (73.7 %) 195 (89.9 %) 70 (49.0 %) 221 (89.5 %) 129 (53.3 %) 133 (56,1 %)
Preferential 235 (24.65 %) 47 (20.3 %) 8 (3.69 %) 45 (31.5 %) 17 (6.88 %) 76 (31.4 %) 42 (17,7 %)
Urgent 164 (17.20 %) 14 (6.03 %) 14 (6.45 %) 28 (19.6 %) 9 (3.64 %) 37 (15.3 %) 62 (26,2 %)
Indication 0,019
Diagnostic suspicion 953 (64.47 %) 164 (66.9 %) 152 (62.0 %) 156 (62.4 %) 165 (66.0 %) 152 (61.5 %) 164 (68,0 %)
Follow-up 355 (24.01 %) 59 (24.1 %) 53 (21.6 %) 66 (26.4 %) 47 (18.8 %) 70 (28.3 %) 60 (24,9 %)
Opportunistic screening 170 (11.50 %) 22 (8.98 %) 40 (16.3 %) 28 (11.2 %) 38 (15.2 %) 25 (10.1 %) 17 (7,05 %)
Type of diagnostic suspicionb 0,012
Rectal bleeding 357 (37.46 %) 53 (32.3 %) 60 (39.5 %) 55 (35.3 %) 71 (43.0 %) 60 (39.5 %) 58 (35,4 %)
Abdominal pain 253 (26.54 %) 48 (29.3 %) 42 (27.6 %) 37 (23.7 %) 36 (21.8 %) 32 (21.1 %) 58 (35,4 %)
Anaemia 160 (16.78 %) 30 (18.3 %) 21 (13.8 %) 32 (20.5 %) 27 (16.4 %) 26 (17.1 %) 24 (14,6 %)
Changes in bowel habit 76 (7.97 %) 20 (12.2 %) 13 (8.55 %) 18 (11.5 %) 13 (7.88 %) 10 (6.58 %) 2 (1,22 %)
Other 107 (11.22 %) 13 (7.93 %) 16 (10.5 %) 14 (8.97 %) 18 (10.9 %) 24 (15.8 %) 22 (13,4 %)
Type of follow-upc <0,001
Adenomas 205 (58.07 %) 22 (37.9 %) 34 (64.2 %) 37 (56.9 %) 37 (78.7 %) 32 (45.7 %) 43 (71,7 %)
CRC 110 (31.16 %) 29 (50.0 %) 14 (26.4 %) 19 (29.2 %) 6 (12.8 %) 35 (50.0 %) 7 (11,7 %)
Ulcerative colitis 16 (4.53 %) 3 (5.17 %) 3 (5.66 %) 2 (3.08 %) 2 (4.26 %) 2 (2.86 %) 4 (6,67 %)
Crohn’s disease 7 (1.98 %) 1 (1.72 %) 0 (0.00 %) 5 (7.69 %) 0 (0.00 %) 1 (1.43 %) 0 (0,00 %)
Diverticular disease 3 (0.85 %) 0 (0.00 %) 1 (1.89 %) 0 (0.00 %) 0 (0.00 %) 0 (0,00 %) 2 (3,33 %)
Other 12 (3.40 %) 3 (5.17 %) 1 (1.89 %) 2 (3.08 %) 2 (4.26 %) 0 (0,00 %) 4 (6,67 %)
aover the total (missing cases excluded)
bOver diagnostic suspicion indication
cOver follow-up indication
CRC Colorrectal cancer
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lowest request percentage (11.50 %). The most frequent in-
dication of diagnostic suspicion request was rectal bleeding
(37.46 %), followed by abdominal pain (26.54 %), and an-
aemia screening (16.78 %). Among follow-up colonos-
copies, the most frequent indication was follow-up of
adenomas (58.1 %) and follow-up of CRC (31.16 %), al-
though these percentages were heterogeneously distributed
at the different participating hospitals. We have found sig-
nificant differences between GP and gastroenterologists
(<0.001) and between GP and surgeons (<0.039). Although
the internist’s adequacy have higher percentage being com-
pared to GP, the differences are not significant (p = 0.346).
According to the EPAGE II criteria, colonoscopies
were evaluated as appropriate in 73.68 % of the patients
(1089/1478; CI 95 % 71.4–75.9), uncertain in 16.57 %
(245/1478; CI 95 % 14.7–18.5), and inappropriate in
9.74 % (144/1478; CI 95 % 8.3–11.4). As detailed in
Table 3, appropriateness of colonoscopy respectively in-
creased in relation to age (85.85 % in patients >50 years
vs. 39.43 % in ≤50 years), priority of request (81.70 % in
urgent priority vs. 70.51 % in routine priority), and clin-
ical indication (79.32 % for diagnostic suspicion vs. 60 %
for previously diagnosed condition follow-up). Changes
in bowel habit and anaemia were the indications for
diagnostic suspicion which presented the highest per-
centages of appropriateness of colonoscopy. Section
‘Other’, which includes constitutional syndrome and ab-
dominal mass, among other, reached 100 % of appropri-
ateness. Follow-up of CRC reached an EPAGE-II ≥7 in
77.27 % of cases, whereas adenomas only in 53.65 %,
despite being the most frequent indication for follow-up
(57.74 %). Regarding the type of requesting clinician,
general practitioners (76.96 %) showed an EPAGE-II ≥7,
slightly higher than the rest of professionals. When
comparing the results of diagnostic appropriateness of
colonoscopy by type of professional for each of the
three categories of indication (diagnostic suspicion,
screening and follow-up), the internists achieved the
highest percentage in the diagnostic suspicion (92 %),
followed by GP (80.8 %). The only significant differ-
ences occur when comparing the GP with surgeons
(70.3 %) (p = 0.011).
Out of the 1.478 colonoscopies, a total of 1.975 diagnoses
were established (Table 4). In 388 cases (19.64 %) colonos-
copy was normal, in 594 cases (30.07 %) haemorrhoids
were diagnosed, and in 51.27 % a relevant diagnosis was
confirmed. Distribution of these diagnoses showed signifi-
cant differences between reference hospitals.
Table 5 presents the EPAGE-II criteria distribution, ac-
cording to the reached diagnoses. 97.82 % of colonoscopies
with a diagnosis of CRC obtained an adequate EPAGE-II
score. This value stands close to 55 % in the IID. In
addition, 70.36 % of colonoscopies with normal results or
with irrelevant diagnosis showed an adequate EPAGE-II.
All included variables shown significant differences on
the bivariate analysis of appropriateness of colonoscopies
(two categories, cut-off point ≥7), except for gender, nor-
mal colonoscopy diagnosis, haemorrhoids, and ‘other
diagnoses’. In the multivariate and multilevel analysis
final model (Table 6), performed colonoscopies reached
an odds ratio (OR) of qualifying as appropriate for CRC
diagnosis of 9.9 (OR = 9.87; CI 95 % 1.16–84.08), 1.5
(OR = 1.49; CI 95 % 1.1–2.02) if the colonoscopy request
was issued by a general practitioner, and 1.1 (OR = 1.09;
CI 95 % 1.07–1.1) if the colonoscopy was performed on
women. OR for colonoscopies to be classified as appro-
priate, increased nearly 10 % for every one year increase
in patient age (OR 1.09; CI 95 % 1.07–1.10). On the
other hand, OR for colonoscopies to be classified as ap-
propriate, decreased if the indication for request was
follow-up (OR 0.23; CI 95 % 0.14–0.38). Colonoscopy
request for diagnostic suspicion, and presence of aden-
omas or IID as colonoscopy result, were explicative vari-
ables (according to the Akaike Information Criteria) in
the model but not statistically significant.
Despite the variable origin of the colonoscopy re-
quest showed significant differences on the bivariate
analysis, this variable was not included in the logistic
regression model due to the interaction and multicolli-
nearity with the colonoscopy requesting clinician. Con-
cordance between the EPAGE-II score assessed by the
first reviewer and the final score obtained by consen-
sus, presented an intraclass correlation coefficient of
0.704 (moderate-good), and a Spearman’s rank correl-
ation coefficient of 0.651.
Discussion
The study results show that, following the EPAGE-II
guidelines, the indications of colonoscopy are appropri-
ate in a high percentage (73.68 %), although, the per-
centage of uncertain, and inappropriate indications
(16.57 % and 9.74 % respectively), are not negligible.
These results are comparable to those obtained in the
individual studies considered in the systematic review by
Hassan et al. [20], where the estimated percentage of un-
certain and inappropriate colonoscopies was 26 %. This
review included 12 cohort studies (14.160 colonoscopies)
performed in countries of Europe and Asia, and assessed
the appropriateness of colonoscopy according to the
EPAGE-II and ASGE criteria [20].
Results on inappropriateness of colonoscopy vary
among the various countries and published studies. A
multicentric study with the participation of 11 European
countries (5,213 colonoscopies), using EPAGE criteria,
positions inappropriateness of colonoscopy in 27 % [21].
Studies conducted in Switzerland situate it at 13–27 %
[22–25], and studies performed in Spain, at 23–31 %
[26, 27]. Studies published from 2009 onwards, used the
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EPAGE-II criteria, and obtained far more satisfactory re-
sults. Therefore, the studies conducted in Spain, based
on the EPAGE-II, situate inappropriateness at 10.5–
17.5 % [28–30], closer to the inappropriateness results of
our study (9.7 %).
The percentage of uncertain colonoscopies in our
study (16.57 %) stands in an average place among the
studies conducted in our setting, which used the
EPAGE-II criteria (between 9.1 % and 18 %) [28–30].
Studies conducted using the EPAGE criteria exhibit a
considerably higher percentage of uncertain colonos-
copies. In fact, the wide number of situations considered
as uncertain by the EPAGE criteria, was the reason for
applying the new EPAGE-II criteria in our study [14].
Table 3 Classification of colonoscopy appropriateness according to the EPAGE II criteria. Characteristics of the patients, clinicians,
and indication of request. Results expressed as n (%). EPAGE II criteria percentages are shown per row
Total N = 1478 (100 %) ≤3 144 (9.7 %) 4-6 245 (16.6 %) ≥7 1089 (73.7 %) p value
Age <0.001
≤50 years 388 (26.25 %) 33 (8.50 %) 202 (52.06 %) 153 (39.43 %)
>50 years 1089 (73.68 %) 111 (10.19 %) 43 (3.94 %) 935 (85.85 %)
Gender 0.145
Women 740 (50.06 %) 66 (8.91 %) 113 (15.27 %) 561 (75.81 %)
Men 738 (49.93 %) 78 (10.56 %) 132 (17.88 %) 528 (71.54 %)
Origin (gathered) <0.001
SCC and outpatients 662 (45.03 %) 86 (12.99 %) 115 (17.37 %) 461 (69.63 %)
PCC 808 (54.49 %) 58 (7.17 %) 128 (15.84 %) 622 (76.98 %)
Requesting clinician 0.001
General practitioner 790 (54.63 %) 57 (7.21 %) 125 (15.82 %) 608 (76.96 %)
Gastroenterologist 426 (29.46 %) 61 (14.31 %) 72 (16.90 %) 293 (68.77 %)
Internist 27 (1.86 %) 1 (3.70 %) 2 (7.40 %) 24 (88.88 %)
Surgeon 152 (10.51 %) 18 (11.84 %) 31 (20.39 %) 103 (67.76 %)
Other 51 (3.52 %) 4 (7.84 %) 10 (19.60 %) 37 (72.54 %)
Priority 0.001
Routine 919 (69.72 %) 105 (11.42 %) 166 (18.06 %) 648 (70.51 %)
Preferential 235 (24.01 %) 14 (5.95 %) 35 (14.89 %) 186 (79.14 %)
Urgent 164 (11.50 %) 6 (3.65 %) 24 (14.63 %) 134 (81.70 %)
Indication <0.001
Diagnostic suspicion 953 (64.47 %) 14 (1.46 %) 186 (19.51 %) 753 (79.32 %)
Follow-up 355 (24.01 %) 117 (32.95 %) 25 (7.04 %) 213 (60.00 %)
Opportunistic screening 170 (11.50 %) 13 (7.64 %) 34 (20.00 %) 123 (72.35 %)
Type of diagnostic suspiciona <0.001
Rectal bleeding 357 (37.46 %) 0 (0.00 %) 106 (29.69 %) 251 (70.30 %)
Abdominal pain abdominal 253 (26.54 %) 1 (0.39 %) 73 (28.85 %) 179 (70.75 %)
Anaemia 160 (16.78 %) 9 (5.62 %) 7 (4.37 %) 144 (90.00 %)
Changes in bowel habit deposicional 76 (7.97 %) 4 (5.26 %) 0 (0.00 %) 72 (94.73 %)
Other 107 (11.22 %) 0 (0.00 %) 0 (0.00 %) 107 (100 %)
Type of follow-upb <0.001
Adenomas 205 (57.74 %) 85 (41.46 %) 10 (4.87 %) 110 (53.65 %)
CRC 110 (30.98 %) 12 (10.90 %) 13 (11.81 %) 85 (77.27 %)
Ulcerative colitis 16 (4.50 %) 9 (56.25 %) 1 (6.25 %) 6 (37.50 %)
Crohn’s disease 7 (1.97 %) 1 (14.28 %) 0 (0.00 %) 6 (85.71 %)
Diverticular disease 3 (0.84 %) 0 (0.00 %) 0 (0.00 %) 3 (100.00 %)
aOver diagnostic suspicion indication
bOver follow-up indication
CRC Colorectal cancer
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In our study, colonoscopies requested by general prac-
titioners exhibited good appropriateness. These results
are similar to those published in some studies in our set-
ting [27, 30], but are not confirmed in other series where
gastroenterologists present better percentages of colon-
oscopy appropriateness [26]. In any case, our results are
not consistent with the statement that inappropriate
colonoscopies, according to studies conducted in USA,
Europe and the Middle East, increase in endoscopy
units that accept patients from PC [31]. However, these
studies may not be comparable, due to the differences
in the various country health systems, and in the use of
protocols and guidelines in PC.
In this regard, the differences in appropriateness of
colonoscopy, found in the various hospitals participat-
ing in the study, may be explained by type of hospital
(tertiary referral hospital -H2, H4, H6- or district hos-
pital -H1, H3, H5-), organization of the various endo-
scopic units, request priority, waiting lists, delay in the
procedure, protocols and circuits, as well as clinician
criteria, including PC physicians requesting the colon-
oscopy. Nevertheless, we do not hold the data that con-
firm to which extent, these factors may have influenced
the appropriateness of colonoscopy results in each en-
doscopy unit participating in the study.
As expected, colonoscopy diagnostic performance was
significantly higher in requests of patients over 50, in ur-
gent requests, and in cases where the indication for request
was diagnostic suspicion. In our series, inappropriate indi-
cation was especially relevant in follow-up of adenomas,
and in follow-up of IID. Colonoscopy uncertain indication,
lay with the request for CRC suspicion, namely, rectal
bleeding and abdominal pain. These results are comparable
to those from studies that used EPAGE-II criteria [28–30].
An adequate colonoscopy indication may contribute to
improve prognosis of patients with CRC. However, an ad-
equate appropriateness of colonoscopy does not guarantee
a high association with CRC diagnosis. In this regard, our
results are similar to those found in other studies [26–30].
Regarding the strengths of this study, we would like to
stress the number of colonoscopies included, along with
the number of participating endoscopy units, in compari-
son with other studies conducted in our setting [26–29].
Moreover, we also emphasize the fact that this study
evaluation was conducted by peer review, analysing dis-
crepancies and seeking agreement, despite this method
entailed, in some cases, double-checking the obtained in-
formation from the colonoscopy requests, and from the
electronic medical records. Unfortunately, the number of
different specialist has not been enough for comparing
Table 5 Distribution of EPAGE II criteria depending on colonoscopy results. Results are expressed as n (%). EPAGE II criteria
percentages are shown per row
Total (n = 1478) ≤3 (n = 144) 4-6 (n = 245) ≥7 (n = 1089) p value
N = 1975 197 301 1477
Normal 388 (19.6426.31 %) 40 (10.30 %) 75 (19.32 %) 273 (70.36 %) 0.134
Haemorrhoids 594 (30.07 %) 44 (7.40 %) 114 (19.19 %) 436 (73.40 %) 0.008
Adenomas 377 (19.08 %) 51 (13.52 %) 32 (8.48 %) 294 (77.98 %) <0.001
Diverticular disease 297 (15.03 %) 36 12.12 %) 27 (9.09 %) 234 (78.78 %) <0.001
CRC 46 (2.32 %) 0 (0.00 %) 1 (2.17 %) 45 (97.82 %) <0.001
IID 24 (1.21 %) 5 (20.83 %) 6 (25.00 %) 13 (54.16 %) 0.056
Other 249 (12.60 %) 21 (8.43 %) 46 (18.44 %) 182 (73.09 %) 0.387
CRC Colorectal cancer, IID Inflammatory Intestinal disease (includes ulcerative colitis, and Crohn’s disease)
p-value corresponds to the Fisher’s exact test
Table 4 Colonoscopy results depending on participating reference hospital. Results are expressed as n (%)
Reference Hospitals
Type of Diagnosis Total (n = 1975) H1 (n = 310) H2 (n = 300) H3 (n = 412) H4 (n =312) H5 (n = 352) H6 (n = 289) P
Normal 388 (19.64 %) 49 (15.81 %) 68 (22.67 %) 31 (7.52 %) 101 (32.37 %) 48 (13.64 %) 91 (31.49 %) <0.001
Haemorrhoids 594 (30.07 %) 130 (41.94) 109 (36.33 %) 130 (31.55 %) 45 (14.42 %) 133 (37.78 %) 47 (16.26 %) <0.001
Adenomas 377 (19.08 %) 49 (15.81 %) 70 (23.33 %) 88 (21.36 %) 56 (17.95 %) 75 (31.31 %) 39 (13.49 %) <0.001
Diverticular disease 297 (15.03 %) 51 (16.45 %) 32 (10.67 %) 42 (10.19 %) 44 (14.10 %) 67 (19.03 %) 61 (21.11 %) 0.001
CRC 46 (2.32 %) 8 (2.58 %) 10 (3.33 %) 8 (1.94 %) 7 (2.24 %) 6 (1.70 %) 7 (2.42 %) 0.932
IID 24 (1.21 %) 5 (1.61 %) 6 (2.00 %) 6 (1.46 %) 0 (0.00 %) 4 (1.14 %) 3 (1.04 %) 0.129
Other diagnosis 249 (12.60 %) 18 (5.81 %) 5 (1.67 %) 107 (25.97 %) 59 (18.91 %) 19 (5.40 %) 41 (14.19 %) <0.001
CRC Colorectal cancer, IID Inflammatory Intestinal disease (includes ulcerative colitis. and Crohn’s disease)
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some of variables categories. For example, the internists’
number who participated in the study was not enough to
reach statistical significance when comparing the categor-
ies of indication.
Despite results on concordance between the EPAGE-II
scores assessed by the first reviewer and final scores ob-
tained by consensus, showed an acceptable index accord-
ing to generic cut-off points, in the context of correlation
between reviewers, they were low values, presenting a
large number of discrepancies. We consider these dis-
crepancies may significantly diminish, if all the neces-
sary information to assess the EPAGE-II were available
to the reviewers, leaving no scope for interpretation.
This limitation of our study is common to the various
published studies, and may be avoided if studies were
conducted prospectively. Assessing colonoscopy indica-
tions prospectively, and concluding whether or not col-
onoscopy results modified patient management, would
provide further elements to determine whether colon-
oscopy requests were appropriate. However, studies
that assess appropriateness of colonoscopy prospect-
ively, obtain similar results [26, 30, 32].
In general, studies on appropriateness of colonoscopy
show there is scope for improvement in the indications of
colonoscopy. Our study demonstrates need for improve-
ment, especially, in the indications for follow-up of aden-
omas, and IID, which are relevant and prevalent conditions
in the PC setting. Otherwise, we have also confirmed that
the EPAGE is not a simple and user friendly tool to be used
in the PC practice. In our PC setting, we consider it is es-
sential to provide clinicians with clinical practice guidelines
(CPG) and agreed by consensus protocols between the dif-
ferent health care levels, with simple, updated, and easy to
implement recommendations, to help adequate decision-
making, both in the sense of recommending colonoscopy,
as well as not recommending it. Recommendations which
will help to control colonoscopy demand, reduce waiting
lists, diminish costs, and simultaneously, detect all path-
ology. In this regard, continuous training of the involved
professionals, along with regular sessions where comments
and feed-back from the colonoscopy results are dis-
cussed, should become crucial objectives. Moreover, ap-
propriateness of colonoscopy requires the availability of
quality endoscopy units, along with well- established
circuits between PC and specialized care.
In our PC setting, we reckon that the results obtained in
our study, especially on the section ‘signs and symptoms
of suspicion’ (rectal bleeding, changes in bowel habit, and
abdominal pain), respond, partly, to the implementation
of the available CPG on the management of rectal bleed-
ing [11], and on prevention of CRC [4]. These CPG were
jointly developed by the Spanish Association of Gastro-
enterology (AEG, by its acronym in Spanish), the Spanish
Society for Family and Community Medicine (semFYC, by
its acronym in Spanish), and the Iberoamerican Cochrane
Centre, which have been widely accepted among clini-
cians. However, it is necessary to emphasize the need for
improvement in the follow-up of adenomas, and comply
with the updated protocols on diagnostic and therapeutic
management, like those recently proposed by the Euro-
pean Society of Gastrointestinal Endoscopy (ESGE) [33].
Conclusions
Appropriateness of colonoscopy requests in our setting,
assessed by the EPAGE-II, shows a favourable situation,
according to the National and International standards.
General practitioners contribute positively to this appro-
priateness level. In order to avoid all those cases of in-
appropriate colonoscopies, and obtain a higher diagnostic
performance, along with reduced costs, and waiting lists,
it is necessary to provide physicians with simple and up-
dated guidelines, which also emphasize recommendations
on not always requesting colonoscopies in the most preva-
lent conditions in PC.
Table 6 Multilevel logistic regression models of appropriateness
of colonoscopy, assuming individuals as first level, and hospitals
as second level. Results are expressed as OR (CI 95 %)
Complete Model AIC Model
Independent variable 0.02 (0.01, 0.04) 0.02 (0.01, 0.04)
Age 1.09 (1.07, 1.1) 1.09 (1.07, 1.1)
Gender
Men Ref. Ref.
Women 1.09 (1.07, 1.1) 1.09 (1.07, 1.1)
Type of requesting clinician
Other Ref. Ref.
General practitioner 1.49 (1.1, 2.02) 1.49 (1.1, 2.02)
Indication
Screening Ref. Ref.
Diagnostic suspicion 1.21 (0.77, 1.89) 1.2 (0.77, 1.88)
Follow-up 0.23 (0.14, 0.38) 0.23 (0.14, 0.38)
Priority
Routine Ref. Ref.
Preferential 1.37 (0.89, 2.1) 1.35 (0.88, 2.07)
Urgent 1.57 (0.92, 2.67) 1.57 (0.92, 2.67)
Colonoscopy result
Adenoma 1.39 (0.97, 2) 1.4 (0.97, 2.01)
CRC 9.87 (1.16, 84.08) 10.07 (1.19, 85.33)
IID 2.54 (0.86, 7.51) 2.54 (0.86, 7.49)
Diverticular disease 0.92 (0.62, 1.35) -
Haemorrhoids 0.96 (0.7, 1.31) -
Other 1.03 (0.68, 1.57) -
CRC Colorectal cancer, IID Inflammatory Intestinal disease (includes ulcerative
colitis, and Crohn’s disease), Ref reference, AIC Model Akaike’s
Information Criterion
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